Clinical Trial Update: Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating metformin as adjuvant therapy in obese patients with knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Tanta University | Conditions: Knee Osteoarthritis | Phase 2, Phase 3 | Status: COMPLETED